Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
Bradwell
A R
AR
Department of Immunology, Medical School, Edgbaston, Birmingham, UK.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology*; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D001324:Autoantigens; D020274:Autoimmune Diseases of the Nervous System / Q000276:immunology*; D015153:Blotting, Western; D002467:Cell Nucleus / Q000276:immunology; D002531:Cerebellum / Q000276:immunology; D004268:DNA-Binding Proteins / Q000276:immunology*; D051959:ELAV Proteins; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D000882:Haplorhini; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D051379:Mice; D009363:Neoplasm Proteins / Q000276:immunology*; D009369:Neoplasms / Q000150:complications / Q000276:immunology; D009419:Nerve Tissue Proteins / Q000276:immunology*; D000090682:Neuro-Oncological Ventral Antigen; D009474:Neurons / Q000276:immunology; D020362:Paraneoplastic Cerebellar Degeneration / Q000209:etiology / Q000276:immunology; D020361:Paraneoplastic Syndromes, Nervous System / Q000209:etiology / Q000276:immunology*; D011689:Purkinje Cells / Q000276:immunology; D016601:RNA-Binding Proteins / Q000276:immunology*; D051381:Rats; D013045:Species Specificity
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001323:Autoantibodies; D001324:Autoantigens; C063762:CDR1 protein, human; C095184:CDR2 protein, human; C483817:Cdr1 protein, mouse; D004268:DNA-Binding Proteins; D051959:ELAV Proteins; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D000090682:Neuro-Oncological Ventral Antigen; D016601:RNA-Binding Proteins